ライフサイエンスコーパス: fetal calf serum

1 -12 medium containing 2 x amino acids and 5% fetal calf serum).

2 presence of tissue culture medium containing fetal calf serum.

3 lls cultured in growth medium containing 10% fetal calf serum.

4 cing agent hydrogen peroxide and slightly by fetal calf serum.

5 elet-derived growth factor BB and 2% or less fetal calf serum.

6 r DMEM media with or without pyruvate and 1% fetal calf serum.

7 st of these dissolves without aggregation in fetal calf serum.

8 eration of WI38 cells in the presence of 10% fetal calf serum.

9 without trypsin in the presence of 5 to 10% fetal calf serum.

10 compared with cells cultured in 1% dialyzed fetal calf serum.

11 hosphate-buffered saline (PBS) buffer and in fetal calf serum.

12 ted with either 50% autologous plasma or 10% fetal calf serum.

13 d in essential modified Eagle's medium + 10% fetal calf serum.

14 ascites fluid, and to remove bovine IgG from fetal calf serum.

15 Dulbecco's modified Eagle's medium with 10% fetal calf serum.

16 astrocytic cell phenotype in the presence of fetal calf serum.

17 EMEM) alone or in EMEM supplemented with 10% fetal calf serum.

18 venom phosphodiesterase, S1 nuclease and in fetal calf serum.

19 t complex was completely inactivated with 2% fetal calf serum.

20 neonatal mouse calvariae, and cultured with fetal calf serum (10% for osteoblast-like cells and 2% f

21 aqueous buffer (PBS) or in media containing fetal calf serum (10%), is rapidly taken-up into culture

22 Fetal calf serum (10%)- and PDGF (10 ng/mL)-stimulated i

23 4 versus 19 +/- 6%, P = 0.01) as well as 10% fetal calf serum (19 +/- 7 versus 31 +/- 6%, P = 0.03).

24 transcriptase as well as their stability in fetal calf serum and in CEM cell extracts.

25 le's minimal essential media (EMEM) with 10% fetal calf serum and Pluronic F-68 or F-127 in concentra

26 ells are grown in low serum conditions (0.1% fetal calf serum) and is observed selectively with trans

27 urrently used clinically (but which contains fetal calf serum), and a serum-free alternative, M2 (mel

28 ed Eagle's medium, nonessential amino acids, fetal calf serum, and beta-mercaptoethanol.

29 after stimulation by lysophosphatidic acid, fetal calf serum, and epidermal growth factor retain act

30 media, cytokines, growth factors, hormones, fetal calf serum, and serum extracts.

31 The effect of gamma interferon, fetal calf serum, and the recombination proficiency of E

32 ring glomerular injury, the effect of PF4 on fetal calf serum- and platelet-derived growth factor (PD

33 s with 12-O-tetradecanoylphorbol-13-acetate, fetal calf serum, anisomycin, UV irradiation, tumor necr

34 Estrogen levels present in fetal calf serum are sufficient to maintain AIB1 mRNA an

35 on in RPMI 1640 medium supplemented with 15% fetal calf serum at 37 degrees C with 5% CO(2) in air.

36 26695 cultured in brucella broth containing fetal calf serum (BBF) alone or supplemented with 100 mi

37 ss-galactosidase, bovine serum albumin, nor fetal calf serum caused an increase in outflow resistanc

38 of cell-based therapies using cells grown in fetal calf serum-containing media, an antibody response

39 Response of cells to stimulation by fetal calf serum could be reproduced by the model, furth

40 Charcoal filtration of fetal calf serum eliminated the block of PPARgamma, wher

41 Fetal calf serum enhanced the stimulatory effect of over

42 ifically in response to IGF-I but not to 10% fetal calf serum, epidermal growth factor, fibroblast gr

43 Growth factors such as fetal calf serum, epidermal growth factor, phorbol 12-my

44 te in Dulbecco's modified Eagle's medium and fetal calf serum, even with supplemental growth factors.

45 Cells cultured in 10% dialyzed fetal calf serum exhibited decreased synthesis of more h

46 growth was measured after 3 to 7 days in 1% fetal calf serum (FCS) + RPMI 1640.

47 Fetal calf serum (FCS) and bone morphogenetic proteins (

48 reduced by stimulation of proliferation with fetal calf serum (FCS) and platelet-derived growth facto

49 sCD44 was isolated from human or fetal calf serum (FCS) by urea solubilization and immuno

50 ltured in modified Ham's F10 medium with 10% fetal calf serum (FCS) for 10 days.

51 se dependent and affected by the presence of fetal calf serum (FCS) in the growth medium.

52 d to culture medium supplemented with 1) 15% fetal calf serum (FCS) only; 2) 1% FCS only; 3) 1% FCS a

53 s stimulated over 50-fold by the addition of fetal calf serum (FCS) to the cell culture medium (RPMI

54 Human TM cells grown in 10% fetal calf serum (FCS) were incubated in 0.1% FCS with 1

55 e medium (minimum essential medium, MEM) and fetal calf serum (FCS) were probed by XANES and EXAFS.

56 HAVSMCs stimulated with fetal calf serum (FCS) were pulsed with bromodeoxyuridin

57 parent deficiency and identified a factor in fetal calf serum (FCS) which is capable of mediating upt

58 were cultured in medium supplemented with 5% fetal calf serum (FCS), anti-CD3 antibody, and interleuk

59 n media containing various concentrations of fetal calf serum (FCS), bovine serum albumin, or porcine

60 rates as control cells when cultured in 0.5% fetal calf serum (FCS), but failed to undergo fetal calf

61 When exposed to 10% fetal calf serum (FCS), there were no differences in gro

62 ured with adherent cells (macrophages) in 1% fetal calf serum (FCS)- or adult mouse serum (AMS)-suppl

63 telencephalic cells cultured in 0.5 or 2.0% fetal calf serum (FCS)-containing medium for 48 hr showe

64 nist concentration-dependent potentiation of fetal calf serum (FCS)-stimulated cell proliferation.

65 etal calf serum (FCS), but failed to undergo fetal calf serum (FCS)-stimulated hyperplasia when grown

66 n culture using medium supplemented with 10% fetal calf serum (FCS).

67 microL TGF-beta2 (TGF-beta2-treated group), fetal calf serum (FCS)/phosphate-buffered saline (PBS; F

68 odified Eagle's medium supplemented with 10% fetal calf serum for up to four passages.

69 mbryonic MM cell line (or, similarly, by 10% fetal calf serum), forms branching tubules under three-d

70 resence of cytokines and 5% heat-inactivated fetal calf serum (HI-FCS).

71 Exposure to fetal calf serum induces GRP cells to differentiate into

72 f NPCCs was achieved in vitro by addition of fetal calf serum, insulin-like growth factor-I, nicotina

73 A combination of fetal calf serum, insulin-like growth factor-I, nicotina

74 leukin-1, platelet-derived growth factor, or fetal calf serum, MCs initiated rapid HA synthesis assoc

75 forming growth factor beta-1 (TGF-beta1) and fetal calf serum on proteoglycan synthesis in corneal fi

76 ific developmental stage and the presence of fetal calf serum or a larval extract in the medium.

77 % +/- 12% 48 hours after incubation with 10% fetal calf serum or epidermal growth factor (5 ng/mL), r

78 -steroidal ecdysone analog RH5992 for either fetal calf serum or larval extract also results in activ

79 fetal calf serum than in that grown with 15% fetal calf serum, suggesting that factors present in the

80 nergistic effect of Tpo was observed both in fetal calf serum-supplemented and serum-depleted medium

81 ted at a concentration of 1 cell per well in fetal calf serum-supplemented and serum-depleted medium.

82 ee medium (SFM) or SFM supplemented with 10% fetal calf serum, TGF-gamma1, TGF-beta2, TGF-beta3, basi

83 fetal cultures grown in the presence of 2.5% fetal calf serum than in that grown with 15% fetal calf

84 tion as well as the individual proteins from fetal calf serum that are associated with lipoplexes.

85 n both LPS-treated RAW 264.7 macrophages and fetal calf serum-treated mouse embryonic fibroblasts, TT

86 tion efficiency of the stable complex in 15% fetal calf serum was 30% of that obtained in the absence

87 When fetal calf serum was included in cartilage cultures, MMP

88 Cell proliferation in response to fetal calf serum was later determined in the presence an

89 Dulbecco's minimal essential medium plus 10% fetal calf serum, were added to new wounds.